Vanguard Group Inc Tg Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 15,387,290 shares of TGTX stock, worth $455 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

15,387,290

Previous 13,691,690 12.38%

Holding current value

$455 Million

Previous $244 Million 47.76%

% of portfolio

0.01%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$17.21 - $25.28 $29.2 Million - $42.9 Million	1,695,600 Added 12.38%	15,387,290 $360 Million
Q2 2024 Aug 13, 2024	BUY	$13.32 - $19.19 $2.06 Million - $2.97 Million	154,858 Added 1.14%	13,691,690 $244 Million
Q1 2024 May 10, 2024	SELL	$13.02 - $21.3 $1.75 Million - $2.86 Million	-134,112 Reduced 0.98%	13,536,832 $206 Million
Q4 2023 Feb 14, 2024	BUY	$6.68 - $18.81 $1.33 Million - $3.76 Million	199,770 Added 1.48%	13,670,944 $233 Million
Q3 2023 Nov 14, 2023	BUY	$8.36 - $26.5 $134,378 - $425,961	16,074 Added 0.12%	13,471,174 $113 Million
Q2 2023 Aug 14, 2023	BUY	$15.48 - $35.0 $1.17 Million - $2.65 Million	75,593 Added 0.56%	13,455,100 $334 Million
Q1 2023 May 15, 2023	SELL	$10.23 - $19.34 $21.7 Million - $41.1 Million	-2,123,257 Reduced 13.7%	13,379,507 $201 Million
Q4 2022 Feb 10, 2023	BUY	$5.01 - $11.83 $3.79 Million - $8.95 Million	756,372 Added 5.13%	15,502,764 $183 Million
Q3 2022 Nov 14, 2022	BUY	$4.57 - $8.4 $7.89 Million - $14.5 Million	1,725,560 Added 13.25%	14,746,392 $87.3 Million
Q2 2022 Aug 12, 2022	BUY	$3.74 - $10.66 $3.33 Million - $9.49 Million	889,869 Added 7.34%	13,020,832 $55.3 Million
Q1 2022 May 13, 2022	BUY	$7.81 - $20.45 $308,698 - $808,306	39,526 Added 0.33%	12,130,963 $115 Million
Q4 2021 Feb 14, 2022	BUY	$15.2 - $35.51 $897,727 - $2.1 Million	59,061 Added 0.49%	12,091,437 $230 Million
Q3 2021 Nov 12, 2021	BUY	$21.78 - $40.45 $6.69 Million - $12.4 Million	307,032 Added 2.62%	12,032,376 $400 Million
Q2 2021 Aug 13, 2021	BUY	$32.5 - $48.96 $381 Million - $574 Million	11,725,344 New	11,725,344 $455 Million

Others Institutions Holding TGTX

# of Institutions

338

Shares Held

88.3M

Call Options Held

2.35M

Put Options Held

1.7M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.29B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Tg Therapeutics, Inc. Transaction History